These Analysts Boost Their Forecasts On Medtronic After Upbeat Q1 Earnings

Medtronic (MDT) surpassed Q1 2026 expectations, reporting sales of $8.58 billion and adjusted EPS of $1.26, both exceeding consensus estimates, driven by 8.4% year-over-year sales growth. The company raised its fiscal year 2026 reported revenue guidance to 6.5%-6.8% and sales guidance to $35.72-$35.82 billion, signaling robust confidence in future performance. This strong financial update, alongside new independent board appointments, propelled Medtronic shares up 4.4% and prompted analysts to raise price targets, indicating a favorable outlook for the medical device giant.

Analysis

Medtronic plc (MDT) demonstrated robust performance in its first-quarter 2026 results, exceeding market expectations on both revenue and earnings. The company reported sales of $8.58 billion against a consensus estimate of $8.38 billion, representing an 8.4% year-over-year increase, with organic growth reaching 4.8%. Adjusted earnings per share came in at $1.26, surpassing the anticipated $1.23. The forward-looking picture was notably strengthened, as Medtronic revised its fiscal 2026 reported revenue growth guidance upwards to a range of 6.5%-6.8% from a prior 4.8%-5.1%, while reiterating its 5% organic growth target. Consequently, the full-year sales forecast was raised to $35.72 billion-$35.82 billion, a range that now sits above the consensus of $35.32 billion. This optimistic outlook is underscored by CEO Geoff Martha's confidence in accelerating revenue growth in the second half of the fiscal year. The positive financial results, coupled with the appointment of two new independent directors, were met with a favorable market response, evidenced by a 4.4% rise in MDT shares and upward price target revisions from analysts, such as Bernstein's move to $98.

Key Decisions for Investors

• Given the strong earnings beat and upwardly revised full-year revenue guidance that surpasses consensus, investors should consider the enhanced fundamental outlook for Medtronic's fiscal year.
• The 4.4% share price increase reflects immediate market optimism, and investors should assess the new analyst price targets of $96-$98 as a benchmark for potential near-term upside from the current trading level of $93.84.
• Investors should closely monitor future earnings calls for progress on the 'major growth drivers' mentioned by the CEO, as the company's ability to accelerate growth in the second half of the fiscal year is now a key market expectation.